羟丙基纤维素基溶球加速阿瑞吡坦的溶解,并结合其过饱和口服给药。

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Jan Kožák, Paul Bühlbecker, Annika Rautenberg, Claire Chrétien, Yann Pellequer, Edmont Stoyanov, Alf Lamprecht
{"title":"羟丙基纤维素基溶球加速阿瑞吡坦的溶解,并结合其过饱和口服给药。","authors":"Jan Kožák, Paul Bühlbecker, Annika Rautenberg, Claire Chrétien, Yann Pellequer, Edmont Stoyanov, Alf Lamprecht","doi":"10.1016/j.ejps.2025.107220","DOIUrl":null,"url":null,"abstract":"<p><p>Spray freeze-drying (SFD) leads to a free-flowing lyophilized powder, providing new therapeutic options. In this work, non-aqueous SFD particles are produced with dimethyl sulfoxide as a spray solvent for obtaining amorphous solid dispersions (ASDs) for oral administration of a poorly water-soluble drug, aprepitant. The SFD process was conducted with the low viscosity hydroxypropyl cellulose grades HPC-SSL or HPC-UL to achieve rapidly dissolving aprepitant powder. Besides different HPC grades, varying solid contents (5 and 10 %) and drug-excipient ratios (20/80, 40/60 and 100/0) were explored and compared to film casted ASDs and analysed regarding particle morphology and characteristics, storage stability, in vitro dissolution and in vivo pharmacokinetic studies in rats. Median particle size of the powder formulations ranged between 300 and 500 µm, increasing HPC content led to amorphous formulations, that remained amorphous for 12 months of storage at 25 °C. Dissolution at pH 1.2 revealed supersaturation across all SFD samples with concentration values twofold and fourfold the saturation concentration for 40/60 and 20/80 drug-excipient ratios respectively. After oral administration to rats, t<sub>max</sub>, c<sub>max</sub> and AUC varied between 2.5-4 h, 1.04-1.24 µg/ml and 5.4-8.1 µg*h/ml respectively. Pharmacokinetic parameters were not affected by HPC grade, but indicate a possible relationship between a decrease of geometric particle density and an increase in bioavailability. Low viscosity HPC grades proved to be suitable excipients for the use in non-aqueous SFD to produce amorphous, rapidly dissolving, low density powders.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107220"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hydroxypropyl cellulose-based lyospheres accelerate dissolution of aprepitant combined with its supersaturation for oral delivery.\",\"authors\":\"Jan Kožák, Paul Bühlbecker, Annika Rautenberg, Claire Chrétien, Yann Pellequer, Edmont Stoyanov, Alf Lamprecht\",\"doi\":\"10.1016/j.ejps.2025.107220\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Spray freeze-drying (SFD) leads to a free-flowing lyophilized powder, providing new therapeutic options. In this work, non-aqueous SFD particles are produced with dimethyl sulfoxide as a spray solvent for obtaining amorphous solid dispersions (ASDs) for oral administration of a poorly water-soluble drug, aprepitant. The SFD process was conducted with the low viscosity hydroxypropyl cellulose grades HPC-SSL or HPC-UL to achieve rapidly dissolving aprepitant powder. Besides different HPC grades, varying solid contents (5 and 10 %) and drug-excipient ratios (20/80, 40/60 and 100/0) were explored and compared to film casted ASDs and analysed regarding particle morphology and characteristics, storage stability, in vitro dissolution and in vivo pharmacokinetic studies in rats. Median particle size of the powder formulations ranged between 300 and 500 µm, increasing HPC content led to amorphous formulations, that remained amorphous for 12 months of storage at 25 °C. Dissolution at pH 1.2 revealed supersaturation across all SFD samples with concentration values twofold and fourfold the saturation concentration for 40/60 and 20/80 drug-excipient ratios respectively. After oral administration to rats, t<sub>max</sub>, c<sub>max</sub> and AUC varied between 2.5-4 h, 1.04-1.24 µg/ml and 5.4-8.1 µg*h/ml respectively. Pharmacokinetic parameters were not affected by HPC grade, but indicate a possible relationship between a decrease of geometric particle density and an increase in bioavailability. Low viscosity HPC grades proved to be suitable excipients for the use in non-aqueous SFD to produce amorphous, rapidly dissolving, low density powders.</p>\",\"PeriodicalId\":12018,\"journal\":{\"name\":\"European Journal of Pharmaceutical Sciences\",\"volume\":\" \",\"pages\":\"107220\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejps.2025.107220\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejps.2025.107220","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

喷雾冷冻干燥(SFD)导致自由流动的冻干粉末,提供新的治疗选择。在这项工作中,非水的SFD颗粒是用二甲基亚砜作为喷雾溶剂生产的,用于获得非晶态固体分散体(asd),用于口服难水溶性药物阿瑞吡坦。采用低粘度羟丙基纤维素等级HPC-SSL或HPC-UL进行SFD工艺,以实现快速溶解的增松剂粉末。除了不同的HPC等级外,还研究了不同固体含量(5%和10%)和药物赋形比(20/80、40/60和100/0)与覆膜asd的颗粒形态和特征、储存稳定性、体外溶出度和大鼠体内药代动力学研究。粉末配方的中位粒径范围在300到500µm之间,增加HPC含量导致非晶态配方,在25°C下储存12个月仍保持非晶态。pH值为1.2时,所有SFD样品的溶解度均为过饱和,浓度分别为药物赋形比为40/60和20/80时饱和浓度的两倍和四倍。大鼠口服给药后,tmax、cmax和AUC分别为2.5 ~ 4 h、1.04 ~ 1.24µg/ml和5.4 ~ 8.1µg*h/ml。药代动力学参数不受HPC等级的影响,但表明几何颗粒密度的降低与生物利用度的增加之间可能存在关系。低粘度HPC被证明是用于非水SFD生产非晶、快速溶解、低密度粉末的合适辅料。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hydroxypropyl cellulose-based lyospheres accelerate dissolution of aprepitant combined with its supersaturation for oral delivery.

Spray freeze-drying (SFD) leads to a free-flowing lyophilized powder, providing new therapeutic options. In this work, non-aqueous SFD particles are produced with dimethyl sulfoxide as a spray solvent for obtaining amorphous solid dispersions (ASDs) for oral administration of a poorly water-soluble drug, aprepitant. The SFD process was conducted with the low viscosity hydroxypropyl cellulose grades HPC-SSL or HPC-UL to achieve rapidly dissolving aprepitant powder. Besides different HPC grades, varying solid contents (5 and 10 %) and drug-excipient ratios (20/80, 40/60 and 100/0) were explored and compared to film casted ASDs and analysed regarding particle morphology and characteristics, storage stability, in vitro dissolution and in vivo pharmacokinetic studies in rats. Median particle size of the powder formulations ranged between 300 and 500 µm, increasing HPC content led to amorphous formulations, that remained amorphous for 12 months of storage at 25 °C. Dissolution at pH 1.2 revealed supersaturation across all SFD samples with concentration values twofold and fourfold the saturation concentration for 40/60 and 20/80 drug-excipient ratios respectively. After oral administration to rats, tmax, cmax and AUC varied between 2.5-4 h, 1.04-1.24 µg/ml and 5.4-8.1 µg*h/ml respectively. Pharmacokinetic parameters were not affected by HPC grade, but indicate a possible relationship between a decrease of geometric particle density and an increase in bioavailability. Low viscosity HPC grades proved to be suitable excipients for the use in non-aqueous SFD to produce amorphous, rapidly dissolving, low density powders.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.60
自引率
2.20%
发文量
248
审稿时长
50 days
期刊介绍: The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信